Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

endocrine · Mechanism Report

Can low-grade inflammation suppress T4-to-T3 conversion?

Low-grade inflammatory signaling can reduce active T3 availability by impairing peripheral T4-to-T3 conversion and increasing thyroid hormone inactivation.

PlausibleJuly 30, 202615 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Low-grade inflammatory signaling can suppress deiodinase-mediated T4-to-T3 conversion, lowering active T3 availability despite adequate T4 supply.

laying out figure…
1 of 2 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim says inflammatory signaling can interfere with deiodinase enzymes, lowering active T3 even when T4 supply is adequate. The mechanism graph frames this as a combined effect of reduced activating conversion and increased inactivation, which can create tissue-level thyroid hormone deprivation despite normal circulating thyroid markers.

Verified conclusion

Systemic inflammatory states can profoundly alter thyroid hormone metabolism independently of thyroid gland function, leading to localized tissue-level thyroid hormone deprivation.

Mechanistic explanations

  • Inactivation of activating enzymes: Pro-inflammatory cytokines, particularly interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α), directly impair the Type 1 (D1) and Type 2 (D2) deiodinase enzymes responsible for converting T4 to active T3. IL-6-induced oxidative stress and intracellular glutathione depletion functionally inactivate the selenoprotein catalytic cycles of these enzymes.
  • Transcriptional suppression: TNF-α recruits nuclear factor kappa B (NF-κB) signaling to repress hepatic DIO1 transcription, while IL-6 competes for essential transcriptional coactivators such as steroid receptor coactivator-1 (SRC-1), reducing D1 expression.
  • Accelerated hormone degradation: Inflammatory signaling simultaneously upregulates Type 3 deiodinase (D3) expression. D3 actively degrades thyroid hormones by converting T4 into inactive reverse T3 (rT3) and converting active T3 into inactive T2, compounding the depletion of active thyroid hormone.

Clinical implications

  • Euthyroid sick syndrome: This combined suppression of activating deiodinases and upregulation of inactivating pathways drives a state of relative tissue hypothyroidism, frequently referred to as Non-Thyroidal Illness Syndrome (NTIS).
  • Deceptive serum markers: Because this pathology occurs in peripheral tissues, standard thyroid panels can be misleading. Patients typically exhibit a depressed free T3 to free T4 (fT3:fT4) ratio, while pituitary-derived thyroid-stimulating hormone (TSH) and circulating T4 levels remain within normal reference ranges.

Bottom line

  • Low-grade inflammatory signaling directly impairs peripheral thyroid activation by downregulating D1/D2 and upregulating D3, leading to diminished active T3 availability at the cellular level despite normal circulating T4 and TSH.

References

  1. IL-6 promotes nonthyroidal illness syndrome by blocking ... — pmc.ncbi.nlm.nih.gov ↗
  2. Thyroid Hormones, Oxidative Stress, and Inflammation - PMC — pmc.ncbi.nlm.nih.gov ↗
  3. Research article — content-assets.jci.org ↗
  4. The relationship between deiodinase activity and ... - PMC — pmc.ncbi.nlm.nih.gov ↗
  5. Type 1 iodothyronine deiodinase in human physiology and disease — joe.bioscientifica.com ↗
  6. Inhibition of type 2,5′-deiodinase by tumor necrosis factor ... — sciencedirect.com ↗
  7. Inhibition of type 2,5'-deiodinase by tumor necrosis factor ... — pubmed.ncbi.nlm.nih.gov ↗
  8. Correlation between inflammatory parameters and pituitary ... — link.springer.com ↗
  9. Physiological role and regulation of iodothyronine deiodinases — pmc.ncbi.nlm.nih.gov ↗
  10. Induction of Type 3 Deiodinase Activity in Inflammatory Cells ... — academic.oup.com ↗
  11. deiodinase in HepG2 hepatocarcinoma cells — pubmed.ncbi.nlm.nih.gov ↗
  12. Metabolism of Thyroid Hormone - Endotext - NCBI Bookshelf — ncbi.nlm.nih.gov ↗
  13. Novel nutraceutical combination restores hepatic deiodinase ... — pmc.ncbi.nlm.nih.gov ↗
  14. Induction of type 3 deiodinase activity in inflammatory cells of mice with chronic local inflammation - PubMed — pubmed.ncbi.nlm.nih.gov ↗
  15. Modeling the nonthyroidal illness syndrome - PubMed — pubmed.ncbi.nlm.nih.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesCan obstructive sleep apnea lower testosterone in men?→Plausible5 sourcesDoes a non-elevated LH with low testosterone suggest secondary hypogonadism?→